심전도(ECG) 스트레스 테스트 시장 보고서(2026년)
Electrocardiograph (ECG) Stress Test Global Market Report 2026
상품코드 : 1938966
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,759,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,770,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,780,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심전도(ECG) 부하 시험 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 39억 4,000만 달러에서 2026년에는 42억 2,000만 달러로, CAGR 7.1%로 확대할 전망입니다. 지난 수년간의 성장 요인으로는 첨단 심전도 장비에 대한 접근성 제한, 러닝머신 기반 부하 테스트에 대한 의존도, 심혈관 질환 유병률 증가, 병원 및 외래 심장학 서비스 확대, 기존 모니터링 기술 채택 등을 들 수 있습니다.

심전도(ECG) 부하 시험 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 54억 8,000만 달러에 달하며, CAGR은 6.7%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 클라우드 및 AI 기반 심전도 솔루션 개발, 재택 및 원격의료 서비스 확대, 웨어러블 심장 모니터 채택 증가, 디지털 헬스 플랫폼과의 통합, 심장병 센터 및 원격 모니터링 기술에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 웨어러블 및 재택 심전도 기기의 보급 확대, 클라우드 기반 및 원격 심전도 솔루션의 사용 증가, 전자의무기록(EMR) 및 전자건강기록(EHR) 시스템과의 통합, 다중 유도 및 무선 심전도 모니터 선호도 증가, 원격 심전도 모니터링 및 환자 안전에 대한 관심 강화 등이 있습니다. 원격 심장 모니터링 및 환자 안전에 대한 관심 강화 등을 꼽을 수 있습니다.

심혈관 질환의 유병률 증가는 향후 심전도 검사(ECG) 시장의 성장을 촉진할 것으로 예측됩니다. 심혈관 질환은 심장마비, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 다양한 병태를 포함합니다. 이러한 질환 증가는 주로 고혈압의 유병률 증가로 인한 것으로, 심장과 혈관의 부담을 증가시켜 심장마비나 뇌졸중의 위험을 증가시킵니다. 심전도 검사(ECG)는 신체적 부하 하에서 심장의 기능을 평가하여 심혈관 질환을 감지하는 데 도움을 줍니다. 이를 통해 휴식 시에는 확인할 수 없는 동맥 협착, 부정맥, 혈류 감소 등의 잠재적 문제를 발견할 수 있습니다. 예를 들어 2024년 10월 미국 질병통제예방센터(CDC)가 발표한 자료에 따르면 미국에서는 연간 약 80만5천명이 심장마비를 앓고 있으며, 이 중 60만5천건이 처음 발병하고, 20만건이 과거 심장마비 병력이 있는 사람에게서 발병하는 것으로 나타났습니다. 이처럼 심혈관 질환의 발생률이 증가함에 따라 심전도 검사(ECG)에 대한 수요가 증가하고 있습니다.

심전도(ECG) 부하 테스트 시장의 주요 기업은 진단 정확도 및 워크플로우 효율성 향상, 심장 관리 시스템내 통합을 촉진하기 위한 기술 혁신에 주력하고 있습니다. 예를 들어 Cardiosoft 기술은 PC 기반 심전도 및 부하 테스트 시스템으로 의사가 휴식 또는 운동 중 심장 활동을 모니터링하고 분석할 수 있으며, 데이터를 쉽게 저장하고 확인할 수 있는 소프트웨어를 갖추고 있습니다. 예를 들어 2025년 3월 미국의 의료 기술 기업 GE헬스케어는 임상의가 신속하게 결과를 얻을 수 있도록 지원하는 동시에 심장 환자에게 중요한 요소인 원활한 데이터 흐름을 보장하는 부하 테스트용 심장 평가 시스템을 도입했습니다. 이 시스템은 고급 심전도 분석, 부하 테스트 기능, 전자의무기록과의 완벽한 호환성을 갖추고 있으며, 효율적인 데이터 관리를 실현합니다. 일반적으로 실시간 모니터링, 사용자 정의 가능한 보고서, 정확한 진단을 지원하는 자동 측정 툴을 갖춘 직관적인 소프트웨어가 포함되어 있습니다. 또한 많은 시스템에서 무선 연결 기능을 갖추고 있으며, 다양한 임상 환경에서 이동성과 적응성을 실현하는 동시에 심장 평가시 고품질 신호 획득과 환자의 안전을 보장합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

An electrocardiograph (ECG) stress test is a diagnostic procedure that records the heart's electrical activity both at rest and during physical or pharmacological stress. This test assesses how well the heart functions under these conditions, helping to detect irregular heart rhythms, blood flow problems, and signs of coronary artery disease by comparing ECG results from resting and stressed states.

The main types of ECG stress testing tools include standalone ECG devices, ECG test software, Holter monitors, event monitors, and portable ECG monitors. Standalone ECG devices operate independently without needing integration with other hospital systems and record and display the heart's electrical signals for diagnostic use. The test types encompass exercise stress tests, pharmacological stress tests, and combined exercise and pharmacological stress tests. Various technologies involved include analog and digital ECG stress testing devices, cloud-based ECG solutions, wearable ECG monitors, and telemedicine-enabled ECG stress tests. These are utilized through multiple sales channels such as direct sales, distributors, online retailers, third-party resellers, and healthcare procurement organizations. The primary end users include hospitals, outpatient clinics, cardiology centers, home healthcare providers, and rehabilitation facilities.

Tariffs have influenced the ECG stress test market by raising costs for imported diagnostic devices, wearable monitors, and advanced software solutions. Segments such as treadmill-based systems, multi-lead wireless monitors, and cloud-based platforms are particularly affected, with Asia-Pacific regions like China and India facing significant import duties. This has led to higher production costs and pricing pressures. However, tariffs have also encouraged local manufacturing, development of cost-effective solutions, and increased domestic innovation in ECG device technologies.

The electrocardiograph (ecg) stress test market research report is one of a series of new reports from The Business Research Company that provides electrocardiograph (ecg) stress test market statistics, including electrocardiograph (ecg) stress test industry global market size, regional shares, competitors with a electrocardiograph (ecg) stress test market share, detailed electrocardiograph (ecg) stress test market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiograph (ecg) stress test industry. This electrocardiograph (ecg) stress test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electrocardiograph (ecg) stress test market size has grown strongly in recent years. It will grow from $3.94 billion in 2025 to $4.22 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to limited access to advanced ecg devices, reliance on treadmill-based stress tests, growing prevalence of cardiovascular diseases, increasing hospital and outpatient cardiology services, adoption of traditional monitoring technologies.

The electrocardiograph (ecg) stress test market size is expected to see strong growth in the next few years. It will grow to $5.48 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to development of cloud-enabled and ai-powered ecg solutions, expansion of home healthcare and telemedicine services, rising adoption of wearable cardiac monitors, integration with digital health platforms, increasing investment in cardiology centers and remote monitoring technologies. Major trends in the forecast period include rising adoption of wearable and home-based ecg devices, increasing use of cloud-based and telemedicine ecg solutions, integration with electronic medical records (emr) and ehr systems, growing preference for multi-lead and wireless ecg monitors, enhanced focus on remote cardiac monitoring and patient safety.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the electrocardiograph (ECG) test market moving forward. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including heart attacks, strokes, and hypertension. The rise in these diseases is largely due to growing rates of high blood pressure, which increases strain on the heart and blood vessels, elevating the risk of heart attacks and strokes. An electrocardiograph (ECG) test assists in detecting cardiovascular issues by assessing how the heart performs under physical stress, uncovering hidden problems such as narrowed arteries, irregular heart rhythms, and reduced blood flow that might not be visible when the body is at rest. For example, in October 2024, the Centers for Disease Control and Prevention, a US government agency, reported that around 805,000 people in the United States suffer a heart attack each year; among these, 605,000 are first-time incidents, and 200,000 occur in people with previous heart attack history. Thus, the growing incidence of cardiovascular diseases is boosting the demand for electrocardiograph (ECG) tests.

Leading companies in the electrocardiograph (ECG) stress test market are concentrating on technological advancements such as cardiosoft technology to improve diagnostic precision, workflow efficiency, and integration within cardiology care systems. Cardiosoft technology is a PC-based ECG and stress testing system that enables physicians to monitor and analyze heart activity during rest or exercise, using software that facilitates easy data storage and review. For instance, in March 2025, GE HealthCare, a US health technology firm, introduced a cardiac assessment system designed for stress testing that helps clinicians quickly gain insights while ensuring smooth data flow-an important factor for cardiac patients. This system features advanced ECG analysis, stress testing functions, and seamless compatibility with electronic medical records for streamlined data management. It typically includes intuitive software with real-time monitoring, customizable reports, and automated measurement tools that aid in accurate diagnoses. Many such systems also offer wireless connectivity to allow mobility and adaptability in different clinical environments while ensuring high-quality signal capture and patient safety during cardiac evaluations.

In January 2023, CAIRE Inc., a US-based manufacturer of medical equipment, acquired MGC Diagnostics Holdings Inc. for an undisclosed sum. This acquisition aims to expand CAIRE Inc.'s global respiratory care portfolio by incorporating MGC Diagnostics' non-invasive technologies, including ECG stress test systems. This move positions CAIRE Inc. to support the entire spectrum of pulmonary care, from early diagnosis to long-term oxygen therapy. MGC Diagnostics Holdings Inc. is a US company specializing in non-invasive cardiorespiratory diagnostic systems, which include electrocardiography stress test equipment.

Major companies operating in the electrocardiograph (ecg) stress test market are Cardinal Health Inc, Koninklijke Philips NV, GE Healthcare Technologies Inc, Nihon Kohden Corporation, BTL Industries Inc, Fukuda Denshi Co Ltd, Neurosoft LLC, Schiller AG, Meditech Equipment Co Ltd, COSMED Srl, MGC Diagnostics Corporation, Allengers Global Healthcare Pvt Ltd, EB Neuro S.p.A, custo med GmbH, Clarity Medical Technologies Pvt Ltd, Cortex Biophysik GmbH, Norav Medical Ltd, Medset Medizintechnik GmbH, Mindray Medical International Limited, iRhythm Technologies Inc, Spacelabs Healthcare Inc, Bionet America Inc

North America was the largest region in the electrocardiograph (ECG) test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiograph (ecg) stress test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electrocardiograph (ecg) stress test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The electrocardiograph (ECG) stress test market consists of revenues earned by entities by providing services such as treadmill stress electrocardiograph testing, pharmacologic stress electrocardiograph testing, stress echocardiography with electrocardiograph monitoring, ambulatory stress electrocardiograph monitoring, and pre- and post-stress rest electrocardiograph testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocardiograph (ECG) stress test market also includes sales of treadmill stress test systems, stress echocardiography systems, wireless electrocardiograph monitoring systems, patch-based electrocardiograph devices, and cardiac stress test simulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electrocardiograph (ECG) Stress Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses electrocardiograph (ecg) stress test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for electrocardiograph (ecg) stress test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrocardiograph (ecg) stress test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Electrocardiograph (ECG) Stress Test Market Characteristics

3. Electrocardiograph (ECG) Stress Test Market Supply Chain Analysis

4. Global Electrocardiograph (ECG) Stress Test Market Trends And Strategies

5. Electrocardiograph (ECG) Stress Test Market Analysis Of End Use Industries

6. Electrocardiograph (ECG) Stress Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Electrocardiograph (ECG) Stress Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Electrocardiograph (ECG) Stress Test Total Addressable Market (TAM) Analysis for the Market

9. Electrocardiograph (ECG) Stress Test Market Segmentation

10. Electrocardiograph (ECG) Stress Test Market Regional And Country Analysis

11. Asia-Pacific Electrocardiograph (ECG) Stress Test Market

12. China Electrocardiograph (ECG) Stress Test Market

13. India Electrocardiograph (ECG) Stress Test Market

14. Japan Electrocardiograph (ECG) Stress Test Market

15. Australia Electrocardiograph (ECG) Stress Test Market

16. Indonesia Electrocardiograph (ECG) Stress Test Market

17. South Korea Electrocardiograph (ECG) Stress Test Market

18. Taiwan Electrocardiograph (ECG) Stress Test Market

19. South East Asia Electrocardiograph (ECG) Stress Test Market

20. Western Europe Electrocardiograph (ECG) Stress Test Market

21. UK Electrocardiograph (ECG) Stress Test Market

22. Germany Electrocardiograph (ECG) Stress Test Market

23. France Electrocardiograph (ECG) Stress Test Market

24. Italy Electrocardiograph (ECG) Stress Test Market

25. Spain Electrocardiograph (ECG) Stress Test Market

26. Eastern Europe Electrocardiograph (ECG) Stress Test Market

27. Russia Electrocardiograph (ECG) Stress Test Market

28. North America Electrocardiograph (ECG) Stress Test Market

29. USA Electrocardiograph (ECG) Stress Test Market

30. Canada Electrocardiograph (ECG) Stress Test Market

31. South America Electrocardiograph (ECG) Stress Test Market

32. Brazil Electrocardiograph (ECG) Stress Test Market

33. Middle East Electrocardiograph (ECG) Stress Test Market

34. Africa Electrocardiograph (ECG) Stress Test Market

35. Electrocardiograph (ECG) Stress Test Market Regulatory and Investment Landscape

36. Electrocardiograph (ECG) Stress Test Market Competitive Landscape And Company Profiles

37. Electrocardiograph (ECG) Stress Test Market Other Major And Innovative Companies

38. Global Electrocardiograph (ECG) Stress Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Electrocardiograph (ECG) Stress Test Market

40. Electrocardiograph (ECG) Stress Test Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기